Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Mankind Pharma Ltd. ( (IN:MANKIND) ) just unveiled an announcement.
Mankind Pharma Ltd. has announced that it received an order from the Office of the Assistant Commissioner, Cuttack, regarding a penalty imposed on its wholly owned subsidiary, Lifestar Pharma Private Limited, which has since merged with the company. The order pertains to alleged mismatches in ITC figures in GST returns for the financial years 2018-19 and 2019-20. Mankind Pharma views the order as arbitrary and plans to appeal, asserting that there is no material impact on its financials or operations.
More about Mankind Pharma Ltd.
Mankind Pharma Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its commitment to affordable healthcare solutions and has a significant presence in the Indian pharmaceutical market.
Average Trading Volume: 33,049
Technical Sentiment Signal: Strong Sell
Current Market Cap: 935.7B INR
See more data about MANKIND stock on TipRanks’ Stock Analysis page.